Xtant Medical Holdings, Inc. (XTNT)

ASE – Real Time Price. Currency in USD

0.42

-0.00 (-0.33%)

At close: Jun 26, 2026, 4:00 PM EDT

0.42

+0.00 (1.17%)

After-hours: Jun 26, 2026, 5:16 PM EDT

16.05.2026

Xtant Medical Q1 Earnings Call Highlights

Xtant Medical NYSEAMERICAN: XTNT raised its full-year 2026 revenue guidance after announcing a distribution agreement that moves the company into the hemostatic agent market, while first-quarter revenue declined from the prior-year period following divestitures and the loss of certain license revenue.

13.05.2026

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

13.05.2026

Xtant Medical Reports First Quarter 2026 Financial Results

Raises full-year 2026 revenue guidance to a range of $101-$105 million Significantly strengthens balance sheet Enters into exclusive U.S. distribution agreement for Dilon Technologies' HEMOBLAST® Bellows product for high-performance hemostasis; hires Dilon's U.S. sales team BELGRADE, Mont., May 13, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the first quarter ended March 31, 2026.

07.05.2026

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

BELGRADE, Mont., May 7, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the first quarter ended March 31, 2026, before the start of trading on Wednesday, May 13, 2026.

06.05.2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

BELGRADE, Mont., May 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced the commercial launch of Trivium™ Shaped, an extension of its Trivium™ bone graft portfolio that is now available in pre‑shaped configurations designed to support handling, preparation, and placement across a range of surgical applications.

13.04.2026

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST ® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic products BELGRADE, Mont. and NEWPORT NEWS, Va.

09.04.2026

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

BELGRADE, Mont., April 9, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), in partnership with the Montana Governor's Office of Community Service (GOCS), today announced support for the Threshold of Life Memorial, a statewide initiative honoring organ, eye, and tissue donors and the lives they have impacted.

Videos

No Data

There is no data to display

Press releases

13.05.2026

Xtant Medical Reports First Quarter 2026 Financial Results

06.05.2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

13.04.2026

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

09.04.2026

Xtant Medical Holdings, Inc. (XTNT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Q1 Earnings Call Highlights

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Videos

No Data

Press releases

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Q1 Earnings Call Highlights

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Videos

No Data

Press releases

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Search stocks

Xtant Medical Holdings, Inc. (XTNT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Q1 Earnings Call Highlights

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Videos

No Data

Press releases

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Xtant Medical Q1 Earnings Call Highlights

Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial

Videos

No Data

Press releases

Xtant Medical Reports First Quarter 2026 Financial Results

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product

Xtant Medical and Montana Governor's Office of Community Service Announce Support for "Threshold of Life" Memorial